3051 — Optimax Technology Balance Sheet
0.000.00%
- TWD3.03bn
- TWD3.96bn
- TWD1.89bn
Annual balance sheet for Optimax Technology, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 237 | 191 | 149 | 260 | 269 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 919 | 794 | 718 | 572 | 742 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 5,267 | 2,184 | 1,833 | 1,532 | 1,622 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2,220 | 2,133 | 1,591 | 1,575 | 1,507 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 8,808 | 4,809 | 4,418 | 4,141 | 4,250 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,453 | 939 | 1,928 | 435 | 565 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 7,563 | 2,775 | 1,982 | 1,696 | 1,661 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 1,245 | 2,034 | 2,436 | 2,446 | 2,589 |
| Total Liabilities & Shareholders' Equity | 8,808 | 4,809 | 4,418 | 4,141 | 4,250 |
| Total Common Shares Outstanding |